e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Malignant pleural effusion management in 2017: a review of recent RCTs
Login
Advanced search
e-learning
resources
COVID-19
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
Global Lung Function Initiative
e-learning
Case reports
CME Online
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
VALUE-Dx
Courses and events
Malignant pleural effusion management: is combining pleurodesis techniques the way forward? Results of the IPC-PLUS trial.
Rahul Bhatnagar (Bristol, United Kingdom)
Source:
International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Session:
Malignant pleural effusion management in 2017: a review of recent RCTs
Session type:
Symposium
Number:
4805
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rahul Bhatnagar (Bristol, United Kingdom). Malignant pleural effusion management: is combining pleurodesis techniques the way forward? Results of the IPC-PLUS trial.. International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Massive pleural effusion presented with a very rare multitude of complication
Malignant pleural effusion management: is combining pleurodesis techniques the way forward? Results of the IPC-PLUS trial.
TIME for a change in practice: insights from the TIME 1, 2, and 3 trials
COVID-19
Disease Areas
Events
Publications
Guidelines
e-learning
VALUE-Dx
Login